These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 31040096

  • 1. Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial.
    Gilbert R, Brown M, Rainford N, Donohue C, Fraser C, Sinha A, Dorling J, Gray J, McGuire W, Gamble C, Oddie SJ, PREVAIL trial team.
    Lancet Child Adolesc Health; 2019 Jun; 3(6):381-390. PubMed ID: 31040096
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
    Gilbert R, Brown M, Faria R, Fraser C, Donohue C, Rainford N, Grosso A, Sinha AK, Dorling J, Gray J, Muller-Pebody B, Harron K, Moitt T, McGuire W, Bojke L, Gamble C, Oddie SJ.
    Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
    [Abstract] [Full Text] [Related]

  • 3. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
    Gilbert RE, Mok Q, Dwan K, Harron K, Moitt T, Millar M, Ramnarayan P, Tibby SM, Hughes D, Gamble C, CATCH trial investigators.
    Lancet; 2016 Apr 23; 387(10029):1732-42. PubMed ID: 26946925
    [Abstract] [Full Text] [Related]

  • 4. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.
    Harron K, Mok Q, Dwan K, Ridyard CH, Moitt T, Millar M, Ramnarayan P, Tibby SM, Muller-Pebody B, Hughes DA, Gamble C, Gilbert RE.
    Health Technol Assess; 2016 Mar 23; 20(18):vii-xxviii, 1-219. PubMed ID: 26935961
    [Abstract] [Full Text] [Related]

  • 5. Peripherally inserted central catheter design and material for reducing catheter failure and complications.
    Schults JA, Kleidon T, Charles K, Young ER, Ullman AJ.
    Cochrane Database Syst Rev; 2024 Jun 28; 6(6):CD013366. PubMed ID: 38940297
    [Abstract] [Full Text] [Related]

  • 6. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM, Chaiyakunapruk N, Lai NA, O'Riordan E, Pau WS, Saint S.
    Cochrane Database Syst Rev; 2016 Mar 16; 3(3):CD007878. PubMed ID: 26982376
    [Abstract] [Full Text] [Related]

  • 7. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM, Chaiyakunapruk N, Lai NA, O'Riordan E, Pau WS, Saint S.
    Cochrane Database Syst Rev; 2013 Jun 06; (6):CD007878. PubMed ID: 23740696
    [Abstract] [Full Text] [Related]

  • 8. A comparative evaluation of antimicrobial coated versus nonantimicrobial coated peripherally inserted central catheters on associated outcomes: A randomized controlled trial.
    Storey S, Brown J, Foley A, Newkirk E, Powers J, Barger J, Paige K.
    Am J Infect Control; 2016 Jun 01; 44(6):636-41. PubMed ID: 27240799
    [Abstract] [Full Text] [Related]

  • 9. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
    Chong HY, Lai NM, Apisarnthanarak A, Chaiyakunapruk N.
    Clin Infect Dis; 2017 May 15; 64(suppl_2):S131-S140. PubMed ID: 28475779
    [Abstract] [Full Text] [Related]

  • 10. Does the antimicrobial-impregnated peripherally inserted central catheter decrease the CLABSI rate in neonates? Results from a retrospective cohort study.
    Bayoumi MAA, van Rens MFPT, Chandra P, Masry A, D'Souza S, Khalil AM, Shadad A, Alsayigh S, Masri RM, Shyam S, Alobaidan F, Elmalik EE.
    Front Pediatr; 2022 May 15; 10():1012800. PubMed ID: 36507144
    [Abstract] [Full Text] [Related]

  • 11. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
    Yamaguchi RS, Noritomi DT, Degaspare NV, Muñoz GOC, Porto APM, Costa SF, Ranzani OT.
    Intensive Care Med; 2017 Aug 15; 43(8):1097-1104. PubMed ID: 28584925
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S, Mazuski JE, Sona C, Schallom M, Boyle W, Buchman TG, Bochicchio GV, Coopersmith CM, Schuerer DJ.
    J Am Coll Surg; 2015 Sep 15; 221(3):739-47. PubMed ID: 26199017
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial-impregnated central venous catheters for prevention of catheter-related bloodstream infection in newborn infants.
    Balain M, Oddie SJ, McGuire W.
    Cochrane Database Syst Rev; 2015 Sep 27; 2015(9):CD011078. PubMed ID: 26409791
    [Abstract] [Full Text] [Related]

  • 14. Comparison of microbial colonization rates between central venous catheters and peripherally inserted central catheters.
    Pitiriga V, Bakalis J, Theodoridou K, Dimitroulia E, Saroglou G, Tsakris A.
    Antimicrob Resist Infect Control; 2023 Aug 07; 12(1):74. PubMed ID: 37550791
    [Abstract] [Full Text] [Related]

  • 15. Long-term central venous access in pediatric patients at high risk: conventional versus antibiotic-impregnated catheters.
    Baskin KM, Hunnicutt C, Beck ME, Cohen ED, Crowley JJ, Fitz CR.
    J Vasc Interv Radiol; 2014 Mar 07; 25(3):411-8. PubMed ID: 24581464
    [Abstract] [Full Text] [Related]

  • 16. Use of impregnated catheters to decrease colonization rates in neonates - A randomized controlled pilot trial.
    Klemme M, Staffler A, De Maio N, Lauseker M, Schubert S, Innocenti P, Wurster TM, Foerster K, Herber-Jonat S, Mittal R, Messner H, Flemmer AW.
    J Neonatal Perinatal Med; 2020 Mar 07; 13(2):231-237. PubMed ID: 31609709
    [Abstract] [Full Text] [Related]

  • 17. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population.
    Weber JM, Sheridan RL, Fagan S, Ryan CM, Pasternack MS, Tompkins RG.
    J Burn Care Res; 2012 Mar 07; 33(4):539-43. PubMed ID: 22210071
    [Abstract] [Full Text] [Related]

  • 18. Peripherally inserted central catheter-associated bloodstream infection: Risk factors and the role of antibiotic-impregnated catheters for prevention.
    Kagan E, Salgado CD, Banks AL, Marculescu CE, Cantey JR.
    Am J Infect Control; 2019 Feb 07; 47(2):191-195. PubMed ID: 30180989
    [Abstract] [Full Text] [Related]

  • 19. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
    Lorente L, Lecuona M, Jiménez A, Raja L, Cabrera J, Gonzalez O, Diosdado S, Marca L, Mora ML.
    Am J Infect Control; 2016 Jan 01; 44(1):50-3. PubMed ID: 26412482
    [Abstract] [Full Text] [Related]

  • 20. Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT.
    Mallucci CL, Jenkinson MD, Conroy EJ, Hartley JC, Brown M, Moitt T, Dalton J, Kearns T, Griffiths MJ, Culeddu G, Solomon T, Hughes D, Gamble C, BASICS study collaborators.
    Health Technol Assess; 2020 Mar 01; 24(17):1-114. PubMed ID: 32238262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.